Delayed graft function in kidney transplantation

Delayed graft function is a form of acute renal failure resulting in post-transplantation oliguria, increased allograft immunogenicity and risk of acute rejection episodes, and decreased long-term survival. Factors related to the donor and prerenal, renal, or postrenal transplant factors related to the recipient can contribute to this condition. From experimental studies, we have learnt that both ischaemia and reinstitution of blood flow in ischaemically damaged kidneys after hypothermic preservation activate a complex sequence of events that sustain renal injury and play a pivotal part in the development of delayed graft function. Elucidation of the pathophysiology of renal ischaemia and reperfusion injury has contributed to the development of strategies to decrease the rate of delayed graft function, focusing on donor management, organ procurement and preservation techniques, recipient fluid management, and pharmacological agents (vasodilators, antioxidants, anti-inflammatory agents). Several new drugs show promise in animal studies in preventing or ameliorating ischaemia-reperfusion injury and possibly delayed graft function, but definitive clinical trials are lacking. The goal of monotherapy for the prevention or treatment of is perhaps unattainable, and multidrug approaches or single drug targeting multiple signals will be the next step to reduce post-transplantation injury and delayed graft function.

[1]  M. Kuhlmann,et al.  Bioflavonoids attenuate renal proximal tubular cell injury during cold preservation in Euro-Collins and University of Wisconsin solutions. , 2003, Kidney international.

[2]  D. Remick,et al.  Neutralization of Groα and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury , 2001 .

[3]  F. Luft,et al.  Inhibition of intercellular adhesion molecule-1 with antisense deoxynucleotides prolongs renal isograft survival in the rat. , 1998, Kidney international.

[4]  R. Wolfe,et al.  Delayed graft function: risk factors and implications for renal allograft survival. , 1997, Transplantation.

[5]  J. Köhl,et al.  Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent from Neutrophils1 , 2003, The Journal of Immunology.

[6]  K. Nadeau,et al.  The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. , 1997, The Journal of clinical investigation.

[7]  U. Boggi,et al.  KIDNEY PRESERVATION WITH UNIVERSITY OF WISCONSIN AND CELSIOR SOLUTION: A PROSPECTIVE MULTICENTER RANDOMIZED STUDY , 2001, Transplantation.

[8]  Des C. Jones,et al.  Genetic determinants of delayed graft function after kidney transplantation. , 2002, Transplantation.

[9]  G. Jhangri,et al.  Time dependency of factors affecting renal allograft survival. , 2000, Journal of the American Society of Nephrology : JASN.

[10]  J. Antonelli,et al.  Endothelin-receptor blockade mitigates the adverse effect of preretrieval warm ischemia on posttransplantation renal function in rats1 , 2003, Transplantation.

[11]  N. Patel,et al.  GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. , 2003, Kidney international.

[12]  S. Davies,et al.  Differential effect of ischaemia-reperfusion injury on anti-oxidant enzyme activity in the rat kidney. , 1995, Experimental nephrology.

[13]  U. Haberkorn,et al.  Assessment of renal graft function by perioperative monitoring of cortical microcirculation in kidney transplantation.1 , 2003, Transplantation.

[14]  N. Ahsan,et al.  Adverse effect of donor vasopressor support on immediate and one-year kidney allograft function. , 1996, Surgery.

[15]  J. Soulillou,et al.  Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. , 1998, Kidney international.

[16]  R. Fennell,et al.  Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival. , 1993, Transplantation proceedings.

[17]  L. Toledo-Pereyra,et al.  A prospective controlled trial of cold-storage versus machine-perfusion preservation in cadaveric renal transplantation. , 1990, Transplantation.

[18]  P. Vereerstraeten,et al.  Prevention of OKT3 nephrotoxicity after kidney transplantation. , 1996, Kidney international. Supplement.

[19]  H. Karakayalı,et al.  Delayed graft function: predictive factors and impact on outcome in living-related kidney transplantations. , 1998, Renal failure.

[20]  D. Durand,et al.  A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. , 1996, Transplantation.

[21]  M. Schnitzler,et al.  A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. , 1999, Transplantation.

[22]  K. Nadeau,et al.  CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. , 1997, Kidney international.

[23]  R. Kucherlapati,et al.  Differential gene expression following early renal ischemia/reperfusion. , 2003, Kidney international.

[24]  P. Bacchetti,et al.  Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  F. Schena,et al.  Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination1, 2 , 2002, Transplantation.

[26]  K. Nath,et al.  The Involvement of Oxidative Stress in the Progression of Renal Injury , 1999, Blood Purification.

[27]  M. Nicholson,et al.  The relative influence of delayed graft function and acute rejection on renal transplant survival , 1996, Transplant international : official journal of the European Society for Organ Transplantation.

[28]  J. Devière,et al.  Preconditioning of donors with interleukin-10 reduces hepatic ischemia-reperfusion injury after liver transplantation in pigs , 2003, Transplantation.

[29]  D. Shoskes,et al.  Delayed graft function: Influence on outcome and strategies for prevention , 2001 .

[30]  H. Rennke,et al.  Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  P. Halloran,et al.  Delayed graft function in renal transplantation: etiology, management and long-term significance. , 1996, The Journal of urology.

[32]  K. Salmela,et al.  A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. , 1999, Transplantation.

[33]  B. Schmidt-nielsen.  Urea excretion in white rats and kangaroo rats as influenced by excitement and by diet. , 1955, The American journal of physiology.

[34]  R. Lauzurica,et al.  Hydration and mannitol reduce the need for dialysis in cadaveric kidney transplant recipients treated with CyA. , 1992, Transplantation proceedings.

[35]  J. Mcintyre,et al.  Antiphospholipid antibodies and renal transplantation: a risk assessment , 2003, Lupus.

[36]  P. Halloran,et al.  Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. , 1995, Transplantation.

[37]  B. Kasiske,et al.  Protective Effect of HMG-CoA Reductase Inhibitor on Experimental Renal Ischemia-Reperfusion Injury , 2002, American Journal of Nephrology.

[38]  S. Amur,et al.  Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury , 2002, Transplantation.

[39]  Lars Bäckman,et al.  INTERLEUKIN-2-RECEPTOR BLOCKADE WITH DACLIZUMAB TO PREVENT ACUTE REJECTION IN RENAL TRANSPLANTATION , 1998 .

[40]  Stefan Fischer,et al.  Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. , 2002, American journal of respiratory and critical care medicine.

[41]  M. Maines,et al.  The heme oxygenase system: a regulator of second messenger gases. , 1997, Annual review of pharmacology and toxicology.

[42]  N. Perico,et al.  Tackling the Shortage of Donor Kidneys: How to Use the Best that We Have , 2003, American Journal of Nephrology.

[43]  A. Gaber,et al.  Routine early biopsy of allografts with delayed function: correlation of histopathology and transplant outcome. , 1996, Clinical transplantation.

[44]  J. Hodler,et al.  Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. , 1987, Journal of Clinical Investigation.

[45]  R. Schrier,et al.  Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. , 1989, Kidney international.

[46]  G. Şener,et al.  Protective effect of N-acetylcysteine on renal ischemia/reperfusion injury in the rat. , 2003, Journal of nephrology.

[47]  M. Suthanthiran,et al.  EXCELLENT OUTCOME WITH A CALCIUM CHANNEL BLOCKER—SUPPLEMENTED IMMUNOSUPPRESSIVE REGIMEN IN CADAVERIC RENAL TRANSPLANTATION: A POTENTIAL STRATEGY TO AVOID ANTIBODY INDUCTION PROTOCOLS , 1993, Transplantation.

[48]  F. Pixley,et al.  Biology and action of colony‐stimulating factor‐1 , 1997, Molecular reproduction and development.

[49]  M. Stegall,et al.  Changes in intragraft gene expression secondary to ischemia reperfusion after cardiac transplantation , 2002, Transplantation.

[50]  R. Colvin,et al.  Expression of heme oxygenase-1 can determine cardiac xenograft survival , 1998, Nature Medicine.

[51]  A. Sagalowsky,et al.  Intraoperative albumin administration affects the outcome of cadaver renal transplantation. , 1992, Transplantation.

[52]  G. Russ,et al.  Perioperative blood pressure control, delayed graft function, and acute rejection after renal transplantation1 , 2003, Transplantation.

[53]  R. Lafayette,et al.  Anaritide in Acute Tubular Necrosis , 1997 .

[54]  A. Matas,et al.  Impact of delayed function on long-term graft survival after solid organ transplantation. , 1999, Transplantation Proceedings.

[55]  R. Junker,et al.  Outcome of kidney transplantation in patients with inherited thrombophilia: data of a prospective study. , 2003, Journal of the American Society of Nephrology : JASN.

[56]  J. Briggs,et al.  Biocompatible membranes do not promote graft recovery following cadaveric renal transplantation. , 2002, Clinical nephrology.

[57]  P. Walker,et al.  Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N(6)-(1-Iminoethyl)lysine. , 2000, The Journal of pharmacology and experimental therapeutics.

[58]  M. Cameron,et al.  The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury. , 2003, Seminars in immunology.

[59]  M. Brezis,et al.  Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. , 1991, The Journal of clinical investigation.

[60]  B. Fuller,et al.  The importance of iron, calcium and free radicals in reperfusion injury: an overview of studies in ischaemic rabbit kidneys. , 1989, Free radical research communications.

[61]  J. Hermans,et al.  Effect of preservation solution on results of cadaveric kidney transplantation , 1992, The Lancet.

[62]  W. Finn,et al.  Protective effect of prostacyclin on postischemic acute renal failure in the rat. , 1987, Kidney international.

[63]  R. Colvin,et al.  Adhesion molecules in renal disease. , 1996, Current opinion in nephrology and hypertension.

[64]  F. Delmonico,et al.  A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1 , 2003, Transplantation.

[65]  Y. Nojima,et al.  Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. , 2003, Journal of the American Society of Nephrology : JASN.

[66]  P. Dent,et al.  The effect of endothelin antagonists on renal ischaemia-reperfusion injury and the development of acute renal failure in the rat. , 2002, Nephrology, Dialysis and Transplantation.

[67]  N. Polissar,et al.  Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. , 2003, Journal of the American Society of Nephrology : JASN.

[68]  A. Novick,et al.  DETRIMENTAL EFFECT OF CYCLOSPORINE ON INITIAL FUNCTION OF CADAVER RENAL ALLOGRAFTS FOLLOWING EXTENDED PRESERVATION Results of a randomized Prospective Study , 1986, Transplantation.

[69]  L. Gesualdo,et al.  Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. , 2004, Journal of the American Society of Nephrology : JASN.

[70]  R. Colvin,et al.  Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[71]  R. Schrier,et al.  Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice. , 1999, American journal of physiology. Renal physiology.

[72]  J. Barry,et al.  Effect of furosemide on dialysis requirement following cadaveric kidney transplantation. , 1985, The Journal of urology.

[73]  I. Doxiadis,et al.  Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins , 1999, Transplant international : official journal of the European Society for Organ Transplantation.

[74]  L. Hunsicker,et al.  Delayed Graft Function: State of the Art, November 10–11, 2000. Summit Meeting, Scottsdale, Arizona, USA , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[75]  M. Entman,et al.  Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. , 1995, The Journal of clinical investigation.

[76]  T. Springer.  Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[77]  J. Tillement,et al.  Trimetazidine reduces renal dysfunction by limiting the cold ischemia/reperfusion injury in autotransplanted pig kidneys. , 2000, Journal of the American Society of Nephrology : JASN.

[78]  D. Shoskes,et al.  Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. , 1999, Transplantation.

[79]  I. Holme,et al.  Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial , 2003, The Lancet.

[80]  V. Farewell,et al.  EARLY FUNCTION AS THE PRINCIPAL CORRELATE OF GRAFT SURVIVAL , 1988 .

[81]  J. Bender,et al.  Transplantation of single and paired pediatric kidneys into adult recipients. , 1997, Journal of the American College of Surgeons.

[82]  U. Kunzendorf,et al.  Protective effects of calcium antagonists in human renal transplantation. , 1992, Kidney international. Supplement.

[83]  B. Myers,et al.  A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF. , 2003, Kidney international.

[84]  G. Opelz,et al.  Serial Peripheral Blood Perforin and Granzyme B Gene Expression Measurements for Prediction of Acute Rejection in Kidney Graft Recipients , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[85]  S. Gullans,et al.  Monitoring changes in gene expression in renal ischemia-reperfusion in the rat. , 2002, Kidney international.

[86]  J. Berlin,et al.  Effect of anti-lymphocyte induction therapy on renal allograft survival: a meta-analysis. , 1997, Journal of the American Society of Nephrology : JASN.

[87]  W. Deen,et al.  Mechanisms of filtration failure during postischemic injury of the human kidney. A study of the reperfused renal allograft. , 1995, The Journal of clinical investigation.

[88]  Roger A. Kaiser,et al.  Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. , 1999, Kidney international.

[89]  L. Matis,et al.  Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. , 1998, Circulation.

[90]  M. Goligorsky,et al.  In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. , 1996, The Journal of clinical investigation.

[91]  A. Hoitsma,et al.  Detrimental effect of acute renal failure on the survival of renal allografts: influence of total ischaemia time and anastomosis time. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[92]  F. Cosio,et al.  Impact of acute rejection and early allograft function on renal allograft survival. , 1997, Transplantation.

[93]  Christopher T. Chan,et al.  Review of clinical outcomes in nocturnal haemodialysis patients after renal transplantation. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[94]  P. Russell,et al.  Induction of IA antigens in murine renal transplants. , 1985, Journal of immunology.

[95]  G. Freeman,et al.  Ischemia-Reperfusion of Rat Myocardium Activates Nuclear Factor-&kgr;B and Induces Neutrophil Infiltration Via Lipopolysaccharide-Induced CXC Chemokine , 2001, Circulation.

[96]  B. Vidne,et al.  Role of anti-tumor necrosis factor-alpha in ischemia/reperfusion injury in isolated rat liver in a blood-free environment. , 2002, Transplantation.

[97]  K. Nadeau,et al.  Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. , 1997, Transplantation.

[98]  K. Hirata,et al.  Apoptosis and necrosis after warm ischemia-reperfusion injury of the pig liver and their inhibition by ONO-1714 , 2003, Transplantation.

[99]  J. Megyesi,et al.  N-acetyl cysteine ameliorates ischemic renal failure. , 1997, The American journal of physiology.

[100]  O. Kämpe,et al.  Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. , 1993, The Journal of clinical investigation.

[101]  C. Smith,et al.  Intercellular adhesion molecule 1 (ICAM‐1) expression and its role in neutrophil‐induced ischemia‐reperfusion injury in rat liver , 1995, Journal of leukocyte biology.

[102]  J. H. van Bockel,et al.  Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. , 1997, Transplantation.

[103]  L. Osborn,et al.  Leukocyte adhesion to endothelium in inflammation , 1990, Cell.

[104]  S. Sacks,et al.  Local synthesis of complement component C3 regulates acute renal transplant rejection , 2002, Nature Medicine.

[105]  F. Gao,et al.  Interleukin-13 gene transfer protects rat livers from antigen-independent injury induced by ischemia and reperfusion1 , 2003, Transplantation.

[106]  L. Hood,et al.  Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. , 2003, Journal of the American Society of Nephrology : JASN.

[107]  T. Slowinski,et al.  Association of Factor V Leiden Mutation with Delayed Graft Function, Acute Rejection Episodes and Long-term Graft Dysfunction in Kidney Transplant Recipients , 2002, Thrombosis and Haemostasis.

[108]  E. Winzeler,et al.  Genomics, gene expression and DNA arrays , 2000, Nature.

[109]  M. Sayegh.  Why do we reject a graft? Role of indirect allorecognition in graft rejection. , 1999, Kidney international.

[110]  P. Huie,et al.  Postischemic injury, delayed function and Na+/K(+)-ATPase distribution in the transplanted kidney. , 1995, Kidney international.

[111]  R. Colvin,et al.  A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. , 1993, Transplantation.

[112]  D. Jeyarajah,et al.  Hypothesis: is renal allograft rejection initiated by the response to injury sustained during the transplant process? , 1999, Kidney international.

[113]  W. Jassem,et al.  Delayed graft function: risk factors and the relative effects of early function and acute rejection on long‐term survival in cadaveric renal transplantation , 1999, Clinical transplantation.

[114]  M. Simonson,et al.  Endothelin up-regulation and localization following renal ischemia and reperfusion. , 1999, Kidney international.

[115]  J. Soulillou,et al.  Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients , 1997, The Lancet.

[116]  G. Tanner,et al.  Effects of renal artery occlusion on kidney function in the rat. , 1973, Kidney international.

[117]  H. Friess,et al.  Pathogenesis of delayed kidney graft function: role of endothelin-1, thromboxane B2, and leukotriene B4. , 1996, Transplantation proceedings.

[118]  P. Wilson,et al.  177: Markers of Renal Development are Present in Embryoid Bodies , 2004 .

[119]  F. Veith,et al.  The fate of the renal transplant with delayed function. , 1973, Surgery, gynecology & obstetrics.

[120]  M. Kitajima,et al.  Transfer Of The Interleukin-1 Receptor Antagonist Gene Into Rat Liver Abrogates Hepatic Ischemia-Reperfusion Injury , 2002, Transplantation.

[121]  N. Ahsan,et al.  Adverse effect of donor vasopressor support on immediate and one-year allograft function kidney , 1996 .

[122]  J. Mcintyre,et al.  Antiphospholipid antibodies are a risk factor for early renal allograft failure. , 1999, Transplantation.

[123]  B. Dunkin,et al.  Laparoscopic live donor nephrectomy: the University of Maryland 3-year experience. , 2000, The Journal of urology.

[124]  K. Abe,et al.  In situ localization of C3 synthesis in experimental acute renal allograft rejection. , 2000, The American journal of pathology.

[125]  S. Borkan,et al.  Transient ischemia or heat stress induces a cytoprotectant protein in rat kidney. , 1991, The American journal of physiology.

[126]  K. Matsushima,et al.  Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. , 2003, Journal of the American Society of Nephrology : JASN.

[127]  M. Mitsnefes,et al.  ACTIVATION OF MITOCHONDRIAL APOPTOTIC PATHWAYS IN HUMAN RENAL ALLOGRAFTS AFTER ISCHEMIA‐REPERFUSION INJURY , 2003, Transplantation.

[128]  N. Perico,et al.  Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. , 2002, Kidney international.

[129]  W K Vaughn,et al.  THE DETRIMENTAL EFFECTS OF DELAYED GRAFT FUNCTION IN CADAVER DONOR RENAL TRANSPLANTATION , 1984, Transplantation.

[130]  J. Dijoseph,et al.  THE EFFECT OF RAPAMYCIN ON KIDNEY FUNCTION IN THE SPRAGUE‐DAWLEY RAT , 1992, Transplantation.

[131]  D. Shoskes,et al.  Nitric oxide synthase activity in renal ischemia-reperfusion injury in the rat: implications for renal transplantation. , 1997, Transplantation.

[132]  L. Mazzucchelli,et al.  Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts. , 2003, Kidney international.

[133]  D. Fairlie,et al.  Protective effect of a new C5a receptor antagonist against ischemia-reperfusion injury in the rat small intestine. , 2002, The Journal of surgical research.

[134]  P. Heeringa,et al.  Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation1 , 2003, Transplantation.

[135]  J. Kalil,et al.  Identification of patients at high risk of graft loss by pre- and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay. , 1997, Transplantation.

[136]  K. Matsushima,et al.  Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8 , 1993, Nature.

[137]  A. Jardine,et al.  Early graft function and patient survival following cadaveric renal transplantation. , 1999, Kidney international.

[138]  E. Sabbaga,et al.  Effect of dialyser biocompatibility on recovery from acute renal failure after cadaver renal transplantation. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[139]  W. Weimar,et al.  Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemia-reperfusion. , 2003, Journal of the American Society of Nephrology : JASN.

[140]  V. Sukhatme,et al.  Localization of the protein product of the immediate early growth response gene, Egr-1, in the kidney after ischemia and reperfusion. , 1991, Cell regulation.

[141]  R. Schrier,et al.  The nature of renal cell injury. , 1997, Kidney international.

[142]  B. Löffler,et al.  Relative preservation of the responsiveness to endothelin-1 during reperfusion following renal ischemia in the rat. , 1991, Journal of cardiovascular pharmacology.

[143]  B. Brenner,et al.  In renal transplantation, one size may not fit all. , 1992, Journal of the American Society of Nephrology : JASN.

[144]  F. Gage,et al.  Ablating the ischemia-reperfusion injury in non-heart-beating donor kidneys. , 1998, Transplantation.

[145]  R. Schrier,et al.  Effects of atrial natriuretic peptide in clinical acute renal failure. , 1994, Kidney international.

[146]  Takaaki Kobayashi,et al.  Effect of prolonged delayed graft function on long-term graft outcome in cadaveric kidney transplantation. , 1994, Clinical transplantation.